43.14

2.59% 1.09

After Hours: 43.14

Twist Bioscience Corp (TWST)

Overview News Price History Option Chain Financials Discussions Forecast

Twist Bioscience Corp stock is traded at $43.14, with a volume of 704.72K. It is up +2.59% in the last 24 hours and down -0.46% over the past month. Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States.

Previous Close:

$42.05

Open:

$41.46

24h Volume:

704.72K

Relative Volume:

1.01

Market Cap:

$2.53B

Revenue:

$277.49M

Net Income/Loss:

$-192.14M

P/E Ratio:

-11.66

EPS:

-3.7

Net Cash Flow:

$-95.52M

1W Performance:

+1.15%

1M Performance:

-0.46%

6M Performance:

+4.68%

1Y Performance:

+131.19%

1-Day Range:

$41.17

$43.19

1-Week Range:

$40.32

$44.14

52-Week Range:

$15.85

$60.90

Twist Bioscience Corp Stock (TWST) Company Profile

Name

Twist Bioscience Corp

Sector

Healthcare (1182)

Industry

Diagnostics & Research (57)

Phone

800-719-0671

Address

681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA

Employee

919

Twitter

@TwistBioscience

Next Earnings Date

2024-11-18

Latest SEC Filings

TWST's Discussions on Twitter

Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-17-24	Upgrade	Goldman	Neutral → Buy
Sep-27-23	Initiated	Berenberg	Buy
Jan-05-23	Initiated	Scotiabank	Sector Outperform
Jan-03-23	Upgrade	Evercore ISI	In-line → Outperform
Mar-02-22	Resumed	Cowen	Outperform
Oct-15-21	Resumed	Cowen	Outperform
Jun-29-21	Initiated	William Blair	Outperform
Jun-04-21	Initiated	Goldman	Neutral
Apr-12-21	Initiated	Piper Sandler	Overweight
Feb-05-21	Downgrade	JP Morgan	Neutral → Underweight
Jan-04-21	Downgrade	Evercore ISI	Outperform → In-line
Oct-20-20	Initiated	SVB Leerink	Mkt Perform
May-31-19	Initiated	Evercore ISI	Outperform
Nov-26-18	Initiated	JP Morgan	Neutral

View All

Twist Bioscience Corp Stock (TWST) Latest News

Oct 31, 2024

Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI - Yahoo Finance

Oct 31, 2024

Signaturefd LLC Acquires 306 Shares of Twist Bioscience Co. (NASDAQ:TWST) - Defense World

Oct 31, 2024

Oct 30, 2024

Twist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population Genomics - Yahoo Finance

Oct 30, 2024

Oct 29, 2024

Allspring Global Investments Holdings LLC Has $3.59 Million Position in Twist Bioscience Co. (NASDAQ:TWST) - Defense World

Oct 29, 2024

Oct 25, 2024

Twist Bioscience Co. (NASDAQ:TWST) COO Sells $97,426.49 in Stock - MarketBeat

Oct 25, 2024

Twist Bioscience president sells $97,428 in stock - Investing.com India

Oct 25, 2024

Twist Bioscience president sells $97,428 in stock By Investing.com - Investing.com South Africa

Oct 25, 2024

Twist Bioscience Co. (NASDAQ:TWST) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Oct 25, 2024

Oct 24, 2024

Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024 - Yahoo Finance

Oct 24, 2024

Oct 22, 2024

Twist Bioscience secures $15 million capital boost - Investing.com

Oct 22, 2024

XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience - Yahoo Finance

Oct 22, 2024

Oct 16, 2024

Twist Bioscience (NASDAQ:TWST) Trading Down 2.4%Time to Sell? - MarketBeat

Oct 16, 2024

Baird maintains on Twist Bioscience shares - Investing.com

Oct 16, 2024